IN THIS ISSUE
The top pharmaceutical companies have been forced to drop prices to get a slice of the Chinese market, but that hasn’t dampened spirits one bit. We find out about China’s growing pharmaceutical market. Plus, we take a look at the role pharmaceutical pollution plays in the rise of superbugs resulting from antimicrobial resistance
Also, we examine why academics struggle to replicate potentially exciting pre-clinical research data, explore an initiative to design a new global gateway that will help government procurement agencies access information on thousands of individual patents anywhere in the world, and ask if the rise of tech behemoths will change pharma forever.
Plus, we find out how C4X Discovery plans to use video game technology to generate novel medicines, investigate whether the global supply chain is ready for the next pandemic, and examine if blockchain could stem the tide of counterfeit drugs in India.
Eloise McLennan, editor